Singapore Bio-Innovations

Singapore Bio-Innovations is a venture capital firm that finances later stage investments.

Number of Investments

Number of Lead Investments

6

1

Singapore Bio-Innovations has made 6 investments. Their most recent investment was on Dec 22, 2008, when Humanigen raised $12M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 22, 2008 Humanigen	Series D	$12M	Biopharma	—
Sep 23, 2008 Humanigen	Series D	$20M	Biopharma	—
Aug 3, 2007 Humanigen	Series C	$20M	Biopharma	Yes
Mar 16, 2005 Humanigen	Series B	$20M	Biopharma	—
Feb 8, 2005 Five Prime Therapeutics	Series Unknown	$45M	Biotechnology	—

Singapore Bio-Innovations has had 3 exits. Singapore Bio-Innovations most notable exits include Humanigen , Five Prime Therapeutics

Date	Company Name	Exit Type	Industry
Aug 7, 2017	Humanigen	IPO	Biopharma	Detail
Sep 18, 2013	Five Prime Therapeutics	M&A	Biotechnology	Detail
Jul 15, 2005	Aderis Pharmaceuticals	M&A	Biopharma	Detail